Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients
Creators
- 1. Laboratoire National de Contrôle des Médicaments, Tunis (Tunisia)
- 2. Service des Laboratoires, Hôpital Habib Thameur, Tunis (Tunisia)
Description
Undifferentiated Nasopharyngeal Carcinoma (NPC) patients show a characteristic pattern of antibody responses to the Epstein-Barr virus (EBV) which is regularly associated with this tumor. However, no EBV-specific cytotoxic activity is detectable by the standard chromium-release assay at both peripheral and intratumoral levels. The mechanisms underlying this discrepancy between the humoral and cellular immune responses in NPC are still unknown, but might be related to an imbalance in immunoregulatory interleukin production. In this report, we investigated the ability of peripheral (PBL) and tumor- infiltrating (TIL) lymphocytes of undifferentiated NPC patients to produce in vitro three interleukins (IL-2, IL-6, IL-10) and three immunoglobulin isotypes (IgM, IgG, IgA). Lymphocytes from 17 patients and 17 controls were cultured in the presence of Pokeweed mitogen (PWM) for 12 days and their culture supernatants were tested for interleukins and immunoglobulins by specific enzyme-linked immunosorbent assays (ELISA). Data were analysed using Student's t-test and probability values below 5% were considered significant. The data obtained indicated that TIL of NPC patients produced significantly more IL-2 (p = 0,0002), IL-10 (p = 0,020), IgM (p= 0,0003) and IgG (p < 0,0001) than their PBL. On the other hand, patients PBL produced significantly higher levels of IL-2 (p = 0,022), IL-10 (p = 0,016) and IgM (p = 0,004) than those of controls. No significant differences for IL-6 and IgA were observed. Taken together, our data reinforce the possibility of an imbalance in immunoregulatory interleukin production in NPC patients. An increased ability to produce cytokines such as IL-10 may underlie the discrepancy between humoral and cellular immune responses characteristic of NPC
Availability note (English)
Available from http://dx.doi.org/10.1186/1471-2407-4-68; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC522818Additional details
Identifiers
Publishing Information
- Journal Title
- BMC cancer (Online)
- Journal Volume
- 4
- Journal Page Range
- p. 68
- ISSN
- 1471-2407
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 46082246
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; CHROMIUM; DATA; ENZYME IMMUNOASSAY; ENZYMES; IMMUNOGLOBULINS; IN VITRO; LYMPHOCYTES; LYMPHOKINES; ONCOGENIC VIRUSES; PATIENTS
- Descriptors DEC
- ANIMAL CELLS; BIOASSAY; BIOLOGICAL MATERIALS; BLOOD; BLOOD CELLS; BODY FLUIDS; CONNECTIVE TISSUE CELLS; DISEASES; ELEMENTS; GLOBULINS; GROWTH FACTORS; IMMUNOASSAY; INFORMATION; LEUKOCYTES; MATERIALS; METALS; MICROORGANISMS; MITOGENS; NEOPLASMS; ORGANIC COMPOUNDS; PARASITES; PROTEINS; SOMATIC CELLS; TRANSITION ELEMENTS; VIRUSES
Optional Information
- Copyright
- Copyright (c) 2004 Fliss-Jaber et al
- Notes
- PMCID: PMC522818; PUBLISHER-ID: 1471-2407-4-68; PMID: 15450122; OAI: oai:pubmedcentral.nih.gov:522818; licensee BioMed Central Ltd.